CN Stock MarketDetailed Quotes
600664 Harbin Pharmaceutical Group
- 4.15
- +0.14+3.49%
Market Closed Dec 12 15:00 CST
10.45BMarket Cap17.08P/E (TTM)
4.20High3.97Low739.27KlotVolume4.01Open4.01Pre Close304.80MTurnover2.94%Turnover Ratio26.43P/E (Static)2.52BShares4.2652wk High2.01P/B10.45BFloat Cap2.4152wk Low4.41Limit Up2.52BShs Float14.17Historical High3.61Limit Down5.74%Amplitude-2.06Historical Low--Dividend TTM4.12Avg Price278.17KlotAsk--Div YieldTTM100Lot Size453.38KlotBid
Harbin Pharmaceutical Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 4.26%12.13B | 4.79%8.03B | -3.73%3.66B | 9.39%15.58B | 21.71%11.63B | 22.03%7.66B | 18.73%3.8B | 9.78%14.24B | 8.59%9.56B | 1.92%6.28B |
| Refunds of taxes and levies | 146.88%2.53M | 316.50%2.22M | -82.37%67.51K | -91.39%1.91M | -93.91%1.02M | -96.76%533.44K | -79.69%382.99K | 385.52%22.15M | 311.04%16.81M | 580.96%16.46M |
| Cash received relating to other operating activities | -44.15%201.77M | -50.80%140.81M | -67.91%71.47M | -12.40%439.37M | 97.96%361.26M | 156.05%286.18M | 195.12%222.7M | 34.77%501.54M | -45.99%182.49M | -41.77%111.77M |
| Cash inflows from operating activities | 2.82%12.33B | 2.81%8.17B | -7.29%3.73B | 8.50%16.02B | 22.94%11.99B | 24.06%7.95B | 22.73%4.02B | 10.60%14.77B | 6.71%9.75B | 0.82%6.41B |
| Goods services cash paid | 5.08%8.49B | 5.22%5.55B | 4.61%2.83B | 9.84%10.89B | 16.13%8.08B | 19.80%5.27B | 20.76%2.71B | 1.38%9.91B | 2.41%6.96B | -3.11%4.4B |
| Staff behalf paid | 0.86%1.02B | -1.26%708.29M | -1.76%396.28M | -1.07%1.37B | 1.92%1.01B | 3.06%717.31M | 2.23%403.38M | -13.85%1.38B | -14.05%995.82M | -13.32%696.02M |
| All taxes paid | 6.16%622.85M | -3.04%422.75M | -19.88%192.39M | 8.85%817.63M | 11.45%586.68M | 26.09%436M | 29.54%240.14M | 4.91%751.13M | 7.51%526.43M | 1.77%345.78M |
| Cash paid relating to other operating activities | 33.91%2.01B | 43.11%1.42B | 18.51%578.06M | -4.73%2B | 33.08%1.5B | 24.08%992.74M | 62.76%487.77M | 48.39%2.1B | 32.25%1.13B | 56.46%800.08M |
| Cash outflows from operating activities | 8.62%12.15B | 9.18%8.1B | 4.17%4B | 6.56%15.07B | 16.39%11.19B | 18.83%7.42B | 22.97%3.84B | 4.67%14.14B | 3.37%9.61B | 0.75%6.24B |
| Net cash flows from operating activities | -77.82%178.66M | -86.15%73.63M | -248.28%-270.8M | 52.66%949.67M | 460.27%805.52M | 221.76%531.46M | 17.91%182.63M | 482.97%622.09M | 192.09%143.77M | 3.60%165.17M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | -95.02%498K | ---- | ---- | ---- | --10M | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | -31.51%589.47K | 570.01%589.47K | ---- | ---- | 1.40%860.71K | --87.98K | --71.11K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -96.85%1.12M | -85.41%292.4K | -99.80%3.77K | -76.20%35.94M | -40.17%35.46M | -95.66%2M | -95.75%1.86M | -14.89%151.03M | -55.87%59.26M | -46.19%46.17M |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --10.09M | ---- | ---- |
| Cash inflows from investing activities | -96.95%1.12M | -85.41%292.4K | -99.80%3.77K | -77.45%36.53M | -47.30%36.54M | -95.66%2M | -95.75%1.86M | -9.16%161.98M | -48.36%69.35M | -46.10%46.24M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 65.59%66.8M | 20.03%30.65M | -9.00%14.75M | -3.47%86.54M | -37.32%40.34M | -50.86%25.53M | -49.14%16.2M | 16.88%89.65M | 72.48%64.36M | 57.93%51.96M |
| Cash paid to acquire investments | --10K | --10K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --156.64M | --157.13M | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -66.17%66.81M | 20.07%30.66M | -9.00%14.75M | 171.26%243.17M | 206.82%197.48M | -50.86%25.53M | -49.14%16.2M | 3.40%89.65M | 72.48%64.36M | 57.93%51.96M |
| Net cash flows from investing activities | 59.18%-65.7M | -29.06%-30.36M | -2.78%-14.74M | -385.67%-206.64M | -3,329.17%-160.93M | -311.16%-23.53M | -219.64%-14.34M | -21.04%72.34M | -94.86%4.98M | -110.82%-5.72M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | -78.06%3.73M | -80.08%2.58M | -74.97%2.57M | -76.36%807.64K | 9.32%16.98M | -16.77%12.93M | -30.96%10.25M |
| Cash from borrowing | 18.48%1.64B | 74.66%1.48B | -1.67%590M | 48.61%3.21B | -15.27%1.39B | -15.84%850M | 3.45%600M | 16.22%2.16B | 37.01%1.64B | 19.05%1.01B |
| Cash received relating to other financing activities | ---- | ---- | ---- | 149.31%448.97M | -46.84%58M | -46.84%58M | --50M | --180.09M | --109.11M | --109.11M |
| Cash inflows from financing activities | 13.52%1.64B | 63.04%1.48B | -9.34%590M | 55.39%3.66B | -17.70%1.45B | -19.37%910.57M | 11.55%650.81M | 25.78%2.36B | 45.33%1.76B | 30.83%1.13B |
| Borrowing repayment | 13.42%1.58B | 45.50%1.3B | -21.57%440M | 66.68%3.38B | -2.84%1.4B | 11.57%891.44M | 0.36%561M | 73.02%2.03B | 22.56%1.44B | -6.71%799M |
| Dividend interest payment | 53.29%50.96M | -12.68%20.24M | -23.67%9.79M | -18.69%44.16M | -17.57%33.24M | -10.62%23.18M | -15.79%12.82M | -11.77%54.3M | -14.01%40.33M | -32.46%25.93M |
| Cash payments relating to other financing activities | -18.33%40.49M | -16.20%25.91M | -1.24%13.94M | -13.11%83.12M | -63.74%49.57M | 23.58%30.92M | -1.16%14.12M | -60.80%95.66M | --136.71M | 16.93%25.02M |
| Cash outflows from financing activities | 13.26%1.68B | 42.05%1.34B | -21.13%463.73M | 61.05%3.51B | -8.37%1.48B | 11.25%945.54M | -0.10%587.94M | 47.42%2.18B | 32.36%1.62B | -7.23%849.96M |
| Net cash flows from financing activities | -1.00%-31.99M | 504.48%141.46M | 100.85%126.27M | -15.28%147.94M | -121.89%-31.67M | -112.52%-34.97M | 1,333.12%62.87M | -55.60%174.62M | 1,645.62%144.69M | 626.89%279.4M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -107.87%-191.46K | -97.40%71.33K | -319.42%-165.25K | -75.32%923.88K | -46.94%2.43M | -1.65%2.74M | 144.93%75.32K | 228.84%3.74M | 691.84%4.59M | 642.38%2.79M |
| Net increase in cash and cash equivalents | -86.87%80.78M | -61.15%184.79M | -168.95%-159.44M | 2.19%891.89M | 106.47%615.34M | 7.71%475.7M | 43.08%231.22M | 173.14%872.79M | 530.09%298.04M | 178.14%441.64M |
| Add:Begin period cash and cash equivalents | 43.21%2.96B | 43.21%2.96B | 43.21%2.96B | 73.25%2.06B | 73.25%2.06B | 73.25%2.06B | 29.66%2.06B | 36.65%1.19B | 32.83%1.19B | 36.65%1.19B |
| End period cash equivalent | 13.34%3.04B | 23.66%3.14B | 21.84%2.8B | 43.21%2.96B | 79.90%2.68B | 55.53%2.54B | 30.89%2.3B | 73.25%2.06B | 79.95%1.49B | 58.45%1.63B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Beijing Xinghua Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Beijing Xinghua Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
